APOBEC3B is an enzymatic source of mutation in breast cancer-Reference-Cited by-同舟云学术

APOBEC3B is an enzymatic source of mutation in breast cancer

Published:2013-02-06 Issue:7437 Volume:494 Page:366-370
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Burns Michael B.,Lackey Lela,Carpenter Michael A.,Rathore Anurag,Land Allison M.,Leonard Brandon,Refsland Eric W.,Kotandeniya Delshanee,Tretyakova Natalia,Nikas Jason B.,Yee Douglas,Temiz Nuri A.,Donohue Duncan E.,McDougle Rebecca M.,Brown William L.,Law Emily K.,Harris Reuben S.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11881.pdf

Reference32 articles.

1. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153–158 (2007)

2. Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228–231 (2010)

3. Sjöblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006)

4. Kumar, A. et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl Acad. Sci. USA 108, 17087–17092 (2011)

5. Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435–439 (2011)

Cited by 724 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4⁺Foxp3E2⁺regulatory T cell frequency predicts breast cancer prognosis and recurrence;2024-09-07

2. Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer;DNA Repair;2024-09

3. Exploiting protein domain modularity to enable synthetic control of engineered cells;Current Opinion in Biomedical Engineering;2024-09

4. The viral origins of breast cancer;Infectious Agents and Cancer;2024-08-26

5. APOBEC3C‐mediated NF‐κB activation enhances clear cell renal cell carcinoma progression;Molecular Oncology;2024-08-26